We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.02B
AUM Growth
+$570M
Cap. Flow
+$123M
Cap. Flow %
1.75%
Top 10 Hldgs %
15.06%
Holding
1,247
New
85
Increased
719
Reduced
392
Closed
47

Top Buys

Rank Stock Value
1
LBTYK icon
Liberty Global Class C
LBTYK
+$10.2M
2
VICI icon
VICI Properties
VICI
+$8.36M
3
ALL icon
Allstate
ALL
+$7.41M
4
UTHR icon
United Therapeutics
UTHR
+$6.59M
5
MMS icon
Maximus
MMS
+$5.9M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 13.94%
3 Financials 13.92%
4 Consumer Discretionary 10.22%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGI icon
576
UGI
UGI
$7.33B
$1.75M 0.02%
37,764
-11,510
-23% -$518K
L icon
577
Loews
L
$23.6B
$1.74M 0.02%
31,814
-483
-1% -$27K
INGR icon
578
Ingredion
INGR
$6.58B
$1.74M 0.02%
19,197
-282
-1% -$26.3K
MANT
579
DELISTED
Mantech International Corp
MANT
$1.73M 0.02%
20,032
+371
+2% +$32.1K
PAYX icon
580
Paychex
PAYX
$42.7B
$1.73M 0.02%
16,071
+805
+5% +$81K
WEX icon
581
WEX
WEX
$6.31B
$1.72M 0.02%
8,882
+306
+4% +$62.7K
BCS icon
582
Barclays
BCS
$94.1B
$1.72M 0.02%
178,177
-29,591
-14% -$302K
WING icon
583
Wingstop
WING
$3.18B
$1.72M 0.02%
10,904
+673
+7% +$97K
E icon
584
ENI
E
$77.5B
$1.72M 0.02%
70,340
-1
-0% -$25
CERN
585
DELISTED
Cerner Corp
CERN
$1.71M 0.02%
21,915
-308
-1% -$23.7K
DELL icon
586
Dell
DELL
$293B
$1.71M 0.02%
33,764
+1,223
+4% +$61.3K
PFG icon
587
Principal Financial Group
PFG
$24.3B
$1.7M 0.02%
26,940
-1,692
-6% -$108K
BIO icon
588
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.69M 0.02%
2,622
+29
+1% +$17.6K
EVBG
589
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.69M 0.02%
12,384
+1,182
+11% +$148K
BHC icon
590
Bausch Health
BHC
$2.34B
$1.67M 0.02%
57,033
+619
+1% +$18.8K
RELX icon
591
RELX
RELX
$62B
$1.67M 0.02%
62,554
+16,721
+36% +$444K
DY icon
592
Dycom Industries
DY
$12.3B
$1.66M 0.02%
22,295
+347
+2% +$29.9K
PPL
593
PPL Corp
PPL
$26.7B
$1.66M 0.02%
59,400
+9,013
+18% +$260K
AWI icon
594
Armstrong World Industries
AWI
$7.84B
$1.65M 0.02%
15,414
-897
-5% -$92.4K
ARE icon
595
Alexandria Real Estate Equities
ARE
$8.56B
$1.65M 0.02%
9,080
+539
+6% +$96.5K
CHX
596
DELISTED
ChampionX
CHX
$1.64M 0.02%
63,952
-3,408
-5% -$82.9K
U icon
597
Unity
U
$18.9B
$1.63M 0.02%
14,849
+605
+4% +$59.4K
CNS icon
598
Cohen & Steers
CNS
$4.3B
$1.63M 0.02%
19,803
+796
+4% +$57.4K
AMP icon
599
Ameriprise Financial
AMP
$48.8B
$1.62M 0.02%
6,519
+227
+4% +$57.2K
AVT icon
600
Avnet
AVT
$7.92B
$1.61M 0.02%
40,187
+6,362
+19% +$274K

Similar funds

Oppenheimer Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer Asset Management held 1,247 positions worth $7.02B, up 8.8% from $6.45B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q2 2021 filing shows 85 new, 719 increased, 392 reduced and 47 closed positions. Its largest new stake was United Therapeutics: 34,595 shares worth $6.21M. The largest sale was Affiliated Managers Group, an estimated $24.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q2 2021 buy was United Therapeutics: 34,595 shares worth $6.21M.
  • Oppenheimer Asset Management added most to Liberty Global Class C in Q2 2021, an estimated $10.2M increase.
  • Oppenheimer Asset Management's biggest Q2 2021 reduction was Affiliated Managers Group, cutting an estimated $24.7M.
  • Oppenheimer Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $5.92M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.02B portfolio in Q2 2021.
  • Oppenheimer Asset Management opened 85 new positions and closed 47 in Q2 2021.
  • Oppenheimer Asset Management's portfolio value rose 8.8% quarter-over-quarter to $7.02B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2021, filed 3 Aug 2021.